Adiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lindgren, Anna ^a   Levin, Malin ^b   Blomqvist, Sandra Rodrigo ^a   Wikström, Johannes ^a   Ahnmark, Andrea ^a   Mogensen, Christina ^a   Böttcher, Gerhard ^a   Bohlooly Y, Mohammad ^a   Borén, Jan ^b   Gan, Li Ming ^a   Lindén, Daniel ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; APOLIPOPROTEIN E; CD36 ANTIGEN; LIPID; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BIOMICROSCOPY; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOLOGY; IN VIVO STUDY; INFLAMMATION; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN DEFICIENCY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; BODY WEIGHT; FEMALE; GENOTYPE; HETEROZYGOTE; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, ADIPONECTIN;

EID: 84893149494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080330     Document Type: Article

References (50)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749. doi:10.1074/jbc.270.45.26746. PubMed: 7592907.
2. Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703. doi:10.1074/jbc.271. 18.10697. PubMed: 8631877. (Pubitemid 26145805)
3. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289. doi:10.1006/bbrc.1996.0587. PubMed: 8619847. (Pubitemid 26136463)
4. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120: 803-812. doi:10.1093/oxfordjournals.jbchem.a021483. PubMed: 8947845. (Pubitemid 26385421)
5. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83. doi:10.1006/bbrc.1999.0255. PubMed: 10092513. (Pubitemid 29299050)
6. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599. doi:10.1161/01.ATV.20.6.1595. PubMed: 10845877. (Pubitemid 30353893)
7. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476. doi:10.1161/01.CIR.100.25.2473. PubMed: 10604883. (Pubitemid 30005109)
8. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89. doi:10.1161/01.ATV.0000048856.22331.50. PubMed: 12524229. (Pubitemid 36091630)
9. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228. doi:10.1016/S0140-6736(03)12255-6. PubMed: 12547549. (Pubitemid 36126226)
10. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB et al. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737. doi:10.1001/jama.291.14.1730. PubMed: 15082700. (Pubitemid 38489895)
11. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. doi:10.1038/90984. PubMed: 11479627. (Pubitemid 32756432)
12. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866. doi:10.1074/jbc.C200251200. PubMed: 12032136. (Pubitemid 34967064)
13. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468. doi:10.1074/jbc.M209033200. PubMed: 12431986. (Pubitemid 36801322)
14. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M et al. (2002) Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277: 37487-37491. doi:10.1074/jbc.M206083200. PubMed: 12138120.
15. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y et al. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770. doi:10.1161/01.CIR.0000042707.50032.19. PubMed: 12451000. (Pubitemid 35396973)
16. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103. doi:10.1038/nm1295. PubMed: 16155579. (Pubitemid 41486832)
17. Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T et al. (2006) Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 26: 224-230. doi:10.1161/01.ATV.0000194076.84568.81. PubMed: 16269667. (Pubitemid 43732254)
18. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114: 361-374. doi:10.1042/CS20070347. PubMed: 18230060. (Pubitemid 351397385)
19. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A et al. (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103: 1057-1063. doi:10.1161/01.CIR.103.8.1057. PubMed: 11222466. (Pubitemid 32200177)
20. Tian L, Luo N, Klein RL, Chung BH, Garvey WT et al. (2009) Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 202: 152-161. doi:10.1016/j.atherosclerosis.2008.04.011. PubMed: 18511057.
21. Tsubakio-Yamamoto K, Matsuura F, Koseki M, Oku H, Sandoval JC et al. (2008) Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochem Biophys Res Commun 375: 390-394. doi:10.1016/j.bbrc. 2008.08.009. PubMed: 18703020.
22. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769. doi:10.1038/nature01705. PubMed: 12802337. (Pubitemid 36735700)
23. Bjursell M, Ahnmark A, Bohlooly YM, William-Olsson L, Rhedin M et al. (2007) Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56: 583-593. doi:10.2337/db06-1432. PubMed: 17327425. (Pubitemid 46348449)
24. Liu Y, Michael MD, Kash S, Bensch WR, Monia BP et al. (2007) Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148: 683-692. PubMed: 17068142.
25. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339. doi:10.1038/nm1557. PubMed: 17268472. (Pubitemid 46376688)
26. Gan LM, Grönros J, Hägg U, Wikström J, Theodoropoulos C et al. (2007) Non-invasive real-time imaging of atherosclerosis in mice using ultrasound biomicroscopy. Atherosclerosis 190: 313-320. doi:10.1016/j. atherosclerosis.2006.03.035. PubMed: 16677654. (Pubitemid 46091789)
27. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509. PubMed: 13428781.
28. Homan R, Anderson MK (1998) Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection. J Chromatogr B Biomed Sci Appl 708: 21-26. doi:10.1016/S0378-4347(97)00651-8. PubMed: 9653942. (Pubitemid 28239884)
29. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N et al. (2011) Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13: 401-412. doi:10.1016/j.cmet.2011.02.010. PubMed: 21459325.
30. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K et al. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309. PubMed: 14557259.
31. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T et al. (2004) Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279: 28670-28674. doi:10.1074/jbc.M402558200. PubMed: 15123726. (Pubitemid 38900150)
32. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y et al. (2001) Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1011-1016. doi:10.1161/01.ATV.21.6.1011. PubMed: 11397712. (Pubitemid 34168661)
33. VanderLaan PA, Reardon CA, Getz GS (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24: 12-22. doi:10.1161/01.ATV.0000105054.43931.f0. PubMed: 14604830. (Pubitemid 38082406)
34. Witting PK, Pettersson K, Letters J, Stocker R (2000) Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20: E26-E33. doi:10.1161/01.ATV.20.8.e26. PubMed: 10938028.
35. Williams H, Johnson JL, Carson KG, Jackson CL (2002) Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 22: 788-792. doi:10.1161/01.ATV.0000014587.66321.B4. PubMed: 12006391. (Pubitemid 34517790)
36. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20: 2587-2592. doi:10.1161/01.ATV.20.12. 2587. PubMed: 11116057.
37. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140. doi:10.1161/01.ATV.14.1.133. PubMed: 8274468.
38. Nawrocki AR, Hofmann SM, Teupser D, Basford JE, Durand JL et al. (2010) Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 30: 1159-1165. doi:10.1161/ATVBAHA.109.195826. PubMed: 20299691.
39. Almabouada F, Diaz-Ruiz A, Rabanal-Ruiz Y, Peinado JR, Vazquez-Martinez R et al. (2013) Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties. J Biol Chem 288: 3112-3125. doi:10.1074/jbc.M112.404624. PubMed: 23255609.
40. Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241. doi:10.1038/35025203. PubMed: 11001066.
41. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC (2002) LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282: E207-E214. PubMed: 11739102.
42. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL et al. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056. doi:10.1172/JCI9259. PubMed: 10772649. (Pubitemid 30217689)
43. Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G et al. (2008) Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res 78: 185-196. doi:10.1093/cvr/cvm093. PubMed: 18065445. (Pubitemid 351430949)
44. Guy E, Kuchibhotla S, Silverstein R, Febbraio M (2007) Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o /apoEo mice. Atherosclerosis 192: 123-130. doi:10.1016/j.atherosclerosis. 2006.07.015. PubMed: 16919281. (Pubitemid 46602310)
45. Febbraio M, Guy E, Silverstein RL (2004) Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol 24: 2333-2338. doi:10.1161/01.ATV.0000148007. 06370.68. PubMed: 15486305. (Pubitemid 39658038)
46. Van Eck M, Singaraja RR, Ye D, Hildebrand RB, James ER et al. (2006) Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 26: 929-934. doi:10.1161/01.ATV.0000208364. 22732.16. PubMed: 16456089. (Pubitemid 43732174)
47. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S et al. (2002) Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22: 630-637. doi:10.1161/01.ATV. 0000014804.35824.DA. PubMed: 11950702. (Pubitemid 34408745)
48. Halvatsiotis I, Tsiotra PC, Ikonomidis I, Kollias A, Mitrou P et al. (2010) Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovasc Diabetol 9: 10. doi:10.1186/1475-2840-9-10. PubMed: 20178558.
49. Kotronen A, Yki-Järvinen H, Aminoff A, Bergholm R, Pietiläinen KH et al. (2009) Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur J Endocrinol 160: 593-602. PubMed: 19208777.
50. Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V et al. (2006) Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes 55: 856-861. doi:10.2337/diabetes.55.03.06.db05-0665. PubMed: 16505255. (Pubitemid 43343248)